EXPERIÊNCIA DOS MONITORES DA DISCIPLINA DE HEMATOLOGIA E HEMOTERAPIA DA UNIRIO DURANTE O PERÍODO DE PANDEMIA DE COVID-19

Autor: G Sadigurschi, KG Frigotto, EB Riscarolli, TLD Santos, VRA Valviesse, LL Bergier, MC Magalhães

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S503- (2021)

Objetivos: Relatar a experiência dos monitores da disciplina de Hematologia e Hemoterapia do curso de Medicina da Universidade Federal do Estado do Rio de Janeiro (UNIRIO) em relação às monitorias ministradas através de plataforma digital durant

Externí odkaz: https://doaj.org/article/45a44219d2764b579f48bf2d1e0d3e77

EXPERIÊNCIA DOS MONITORES DA DISCIPLINA DE HEMATOLOGIA E HEMOTERAPIA DA UNIRIO DURANTE O PERÍODO DE PANDEMIA DE COVID-19

Autor: LL Bergier, M.C. Magalhães, G Sadigurschi, EB Riscarolli, T.L.D. Santos, Vra Valviesse, KG Frigotto

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S503-(2021)
Hematology, Transfusion and Cell Therapy

Objetivos: Relatar a experiência dos monitores da disciplina de Hematologia e Hemoterapia do curso de Medicina da Universidade Federal do Estado do Rio de Janeiro (UNIRIO) em relação às monitorias ministradas através de plataforma digital durant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a9dc36e05137b1b847ee78ee798daa3
https://doi.org/10.1016/j.htct.2021.10.867

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia.

Autor: Maciel ALT; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil., Barbosa TDC; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil., Blunck CB; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil., Wolch K; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil., Machado AAL; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil., da Costa ES; Department of Paediatrics, Instituto de Puericultura e Pediatria Martagão Gesteira, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Bergier LL; Onco-Haematology Section, Prontobaby Hospital da Criança Ltda, Rio de Janeiro, Brazil., Schramm MT; Onco-Haematology Section, Prontobaby Hospital da Criança Ltda, Rio de Janeiro, Brazil; Haematology Unit, Hospital do Câncer I, Instituto Nacional de Câncer - INCA, Rio de Janeiro, Brazil., Ikoma-Coltutato MRV; Flow Cytometry Laboratory, Amaral Carvalho Foundation, Jaú, SP, Brazil; Sabin Medicina Diagnóstica, Federal District, Brasília, Brazil., Lins MM; Paediatric Oncology Unit, Instituto de Medicina Integral Prof Fernando Figueira, Recife, PE, Brazil., Aguiar TF; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil; Onco-Haematology Section, Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti, Rio de Janeiro, Brazil., Mansur MB; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital and MRC Weatherall Institute of Molecular Medicine - WIMM, University of Oxford, Oxford, UK. Electronic address: mmansur@inca.gov.br., Emerenciano M; Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Research Centre, Instituto Nacional de Câncer - INCA, Rua André Cavalcanti, 37, Rio de Janeiro, RJ, 20231050, Brazil. Electronic address: memerenciano@inca.gov.br.

Publikováno v: Translational oncology [Transl Oncol] 2022 Jan; Vol. 15 (1), pp. 101291. Date of Electronic Publication: 2021 Nov 23.